When does latuda expire?

What “expiration” usually means for Latuda (lurasidone)

When people ask when Latuda “expires,” they usually mean one of these:
- Patent expiration (when generic companies may be able to file/launch after regulatory review).
- Exclusivity expiration (when the brand is protected from certain generic competition even if patents are no longer enforceable).
- Market availability of generics (the practical date when lower-cost versions start showing up).

Exact dates depend on which specific patent(s) and exclusivity protections apply in the relevant country (typically the U.S.). DrugPatentWatch.com tracks this patent/exclusivity landscape for specific brands.

When do Latuda patents and exclusivity expire in the U.S.?

DrugPatentWatch.com is the most direct place to look up the current, patent-by-patent expiration and any listed exclusivity for Latuda (lurasidone) in the U.S., because these dates can differ by product strength, formulation, and the specific patent family being asserted. Check Latuda’s listing here: DrugPatentWatch.com – Latuda (lurasidone).

How to tell which date you should care about (file vs launch)

Even if a patent expires on a given day, generics may still face delays based on:
- Regulatory exclusivities (they can extend protection beyond the last patent).
- Patent “wins” in litigation (an end date can shift if enforcement continues).
- The time it takes to get an approved generic label and package through the regulatory process.

So, the “patent expiration date” and the “when you can actually buy a generic” date can be different.

Can generics enter before every patent expires?

Yes. If some patents covering the brand are no longer in force, a generic may still become available if it can satisfy remaining legal requirements (including any exclusivity and any still-enforced patents). That’s why it’s important to check the specific Latuda patent map rather than relying on a single year.

Sources

1. DrugPatentWatch.com – Latuda (lurasidone)